Search results
Move Over, Mounjaro. Eli Lilly Has Another Blockbuster in the Making
Motley Fool via Yahoo Finance· 12 hours agoPerhaps the most well-known GLP-1 drugs are diabetes medication Ozempic and obesity care treatment...
Eli Lilly and Company (NYSE:LLY) Price Target Raised to $1,001.00
ETF DAILY NEWS· 17 hours agoEli Lilly and Company (NYSE:LLY – Free Report) had its price target hoisted by BMO Capital Markets from $900.00 to $1,001.00 in a report released on Wednesday ...
Analysts reveal Eli Lilly stock price targets after earnings
TheStreet via Yahoo Finance· 2 days agoThe people at Eli Lilly (LLY) say they're working as fast as they can. The drugmaker, which reported...
Eli Lilly Raised Its Outlook. Is the Stock a Buy Now?
Motley Fool via Yahoo Finance· 15 hours agoEli Lilly (NYSE: LLY) stock has been a top performer thanks to runaway sales of its...
Truist Financial Raises Eli Lilly and Company (NYSE:LLY) Price Target to $892.00
ETF DAILY NEWS· 17 hours agoEli Lilly and Company (NYSE:LLY – Free Report) had its price target boosted by Truist Financial from $850.00 to $892.00 in a report released on Wednesday ...
Eli Lilly reports $2 billion from Mounjaro, Zepbound in Q1 2024
Yahoo Finance via AOL· 4 days agoEli Lilly (LLY) missed Wall Street consensus estimates on Mounjaro sales for the first quarter of...
Eli Lilly and Company (NYSE:LLY) Just Released Its First-Quarter Earnings: Here's What Analysts...
Simply Wall St. via Yahoo Finance· 3 days agoIt's been a good week for Eli Lilly and Company (NYSE:LLY) shareholders, because the company has...
Eli Lilly beats on quarterly profit, hikes full-year guidance on strong sales of Zepbound, Mounjaro
CNBC· 5 days agoEli Lilly on Tuesday reported first-quarter adjusted profit that topped Wall Street's expectations and hiked its full-year guidance on strong sales of its ...
Eli Lilly (LLY) Q1 Earnings Top, Sales Miss, 2024 View Raised
Zacks via Yahoo Finance· 4 days agoEli Lilly (LLY) beats first-quarter estimates for earnings but misses the same for sales. It raises...
Can Pfizer Challenge Lilly and Novo Nordisk in the Obesity Market?
Motley Fool via Yahoo Finance· 14 hours agoWeight loss translates to investor profits. Just look at Eli Lilly and Novo Nordisk. Both stocks...